Patent details

EP2797416 Title: SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION

Basic Information

Publication number:
EP2797416
PCT Application Number:
US2012072177
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP128625258
PCT Publication Number:
WO2013102142
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SUBSTITUTED BENZALDEHYDE COMPOUNDS AND METHODS FOR THEIR USE IN INCREASING TISSUE OXYGENATION
French Title of Invention:
COMPOSÉS BENZALDÉHYDE SUBSTITUÉS ET PROCÉDÉS D'UTILISATION DE CEUX-CI DANS L'AUGMENTATION DE L'OXYGÉNATION DES TISSUS
German Title of Invention:
SUBSTITUIERTE BENZALDEHYDVERBINDUNGEN UND VERFAHREN ZU DEREN VERWENDUNG BEI DER ERHÖHUNG EINER GEWEBEOXIGENIERUNG
SPC Number:
LUC00276

Dates

Filing date:
28/12/2012
Grant date:
09/08/2017
EP Publication Date:
05/11/2014
PCT Publication Date:
04/07/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/08/2017
EP B1 Publication Date:
09/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/12/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/07/2022
 
 

Name:
GLOBAL BLOOD THERAPEUTICS, INC.
Address:
181 Oyster Point Blvd.,, 94080, South San Francisco, CA, United States (US)

History of Owners

From:
09/08/2017
To:
21/07/2022

Name:
Global Blood Therapeutics, Inc.
Address:
400 East Jamie Court Suite 101, South San Francisco, CA 94080, United States (US)

Agent

Name:
Office FREYLINGER S.A.
From:
27/09/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
MORGAN, Bradley
Address:
United States (US)

2

Name:
METCALF, Brian
Address:
United States (US)

3

Name:
WARRINGTON, Jeffrey
Address:
United States (US)

4

Name:
CHUANG, Chihyuan
Address:
United States (US)

5

Name:
HUA, Lan
Address:
United States (US)

6

Name:
JACOBSON, Matthew P.
Address:
United States (US)

7

Name:
PAULVANNAN, Kumar
Address:
United States (US)

Priority

1

Priority Number:
201161581053 P
Priority Date:
28/12/2011
Priority Country:
United States (US)

2

Priority Number:
201261661320 P
Priority Date:
18/06/2012
Priority Country:
United States (US)

Classification

IPC classification:
A01N 35/00; A61K 31/11; A61K 31/192; A61K 31/235; A61K 31/41; A61K 31/416; A61K 31/437; A61K 31/4406; A61K 31/4439; C07C 65/21; C07C 65/30; C07C 69/76; C07D 211/62; C07D 213/30; C07D 213/80; C07D 215/14; C07D 231/56; C07D 257/04; C07D 401/04; C07D 471/04; C07D 487/04;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2022/09
Publication date:
01/08/2022
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
201732
Publication date:
09/08/2017
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name/address
Deed Number:
RC20220000266A
Date Registered:
21/07/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Dennemeyer & Associates S.A.
Journal Edition Number:
Text:
Change of address
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
GLOBAL BLOOD THERAPEUTICS, INC.
Address:
181 Oyster Point Blvd.,, 94080, South San Francisco, CA, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/11/2024
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
21/07/2022 Request For Change 1
21/07/2022 Outgoing Correspondence 1
02/10/2017 Outgoing Correspondence 1
27/09/2017 Power Of Attorney 1